Breaking News - The Fly

Open Search

LNTH

Lantheus

$

()

Lantheus director sells $6.13M in common stock

LNTH

3/5/2024 - 21:21pm

Perspective Therapeutics acquires CGMP-compliant manufacturing facility

CATX , LNTH

3/5/2024 - 08:15am

Lantheus announces FDA approval of DEFINITY for pediatric patients

LNTH

3/4/2024 - 08:37am

Lantheus management to meet with B. Riley

LNTH

3/1/2024 - 04:55am

Lantheus appoints Amanda Morgan as CCO

LNTH

2/28/2024 - 08:32am

Lantheus price target raised by $2 at Truist, here's why

LNTH

2/26/2024 - 09:51am

Lantheus management to meet with B. Riley

LNTH

2/23/2024 - 11:15am

Lantheus price target raised by $14 at JonesResearch, here's why

LNTH

2/23/2024 - 09:00am

Lantheus sees Q1 adjusted EPS $1.50-$1.54, consensus $1.51

LNTH

2/22/2024 - 07:05am

Lantheus sees FY24 adjusted EPS $6.50-$6.70, consensus $6.25

LNTH

2/22/2024 - 07:05am

Lantheus reports Q4 adjusted EPS $1.75, consensus $1.45

LNTH

2/22/2024 - 07:04am

Lantheus announces collaboration with NIA-sponsored study called CLARiTI

LNTH

2/13/2024 - 12:02pm

Lantheus reaffirms 2023 revenue view $1.295B-$1.297B, consensus $1.28B

LNTH

1/23/2024 - 07:48am

Lantheus CEO Mary Anne Heino to retire, Brian Markison to succeed

LNTH

1/23/2024 - 07:47am

Lantheus announces acceptance of its first-to-file ANDA for generic LUTATHERA

LNTH

1/11/2024 - 08:05am